These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8296246)

  • 1. [The genetic aspects of the development of diabetic nephropathy (a review of the literature)].
    Dedov II; Shestakova MV; Mozgovaia ME
    Ter Arkh; 1993; 65(10):9-13. PubMed ID: 8296246
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic nephropathy: an hypothesis regarding genetic susceptibility for the disorder.
    Seaquist ER; Goetz FC; Povey S
    Minn Med; 1986 Aug; 69(8):457-9. PubMed ID: 3762514
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for development of diabetic nephropathy: a review.
    Strojek K; Grzeszczak W; Ritz E
    Nephrol Dial Transplant; 1997; 12 Suppl 2():24-6. PubMed ID: 9269695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of diabetic nephropathy--old buddies and newcomers part 1.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):571-6. PubMed ID: 20658438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors and susceptibility to diabetic nephropathy.
    N Engl J Med; 1988 Jul; 319(3):180-2. PubMed ID: 3386702
    [No Abstract]   [Full Text] [Related]  

  • 7. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic nephropathies: therapeutic aspects].
    Bulliard C; Fontana E; Ruiz J
    Praxis (Bern 1994); 2001 Dec; 90(51-52):2266-71. PubMed ID: 11820169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing genetic susceptibility to diabetic nephropathy.
    Tanaka N; Babazono T
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
    Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
    Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perinatal factors can be risk factors of diabetic nephropathy].
    Rudberg S
    Lakartidningen; 2000 Jan; 97(4):317-9. PubMed ID: 10684225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
    Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus.
    Chowdhury TA; Dyer PH; Kumar S; Gough SC; Gibson SP; Rowe BR; Smith PR; Dronsfield MJ; Marshall SM; Mackin P; Dean JD; Morris PJ; Davies S; Dunger DB; Boulton AJ; Barnett AH; Bain SC
    Diabet Med; 1997 Oct; 14(10):837-40. PubMed ID: 9371475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of diabetic nephropathy.
    Maeda S
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):363-71. PubMed ID: 19124434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy.
    Weiher H; Zwacka RM
    Clin Lab; 2007; 53(1-2):85-8. PubMed ID: 17323831
    [No Abstract]   [Full Text] [Related]  

  • 20. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
    Batlle D; Soler MJ; Wysocki J
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.